🔎 Trials Near Me

Acasă › Boala Crohn › Maryland

Studii clinice pentru Boala Crohn în Maryland

15 studii pentru Boala Crohn caută participanți în Maryland.

Orașe în Maryland

Text oficial al studiului (în engleză)

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

  • National Institutes of Health Clinical Center, Bethesda
În curs de recrutareStudiu observațional
Vârste de la 18 la 85 · Toate sexele · Actualizat 2 oct. 2026 · NCT07619547

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Walter Reed National Military Medical Center ( Site 5006), Bethesda
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Capital Digestive Care, Chevy Chase
  • Woodholme Gastroenterology, Glen Burnie
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Metropolitan Gastroenterology Group - Chevy Chase /ID# 265877, Chevy Chase
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Woodholme Gastroenterology Associates, Glen Burnie
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Chevy Chase Clinical Research, Chevy Chase
  • Woodholme Gastroenterology Associates, Glen Burnie
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • Woodholme Gastroenterology Associates, Glen Burnie
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Capital Digestive Care - Chevy Chase, Chevy Chase
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Mercy Medical Center, Baltimore-Site Number: 8400117, Baltimore
  • Mid-Atlantic GI Research, LLC-Site Number: 8400106, Laurel
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 23 sept. 2026 · NCT07184931

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

  • National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 1/2
Vârste de la 18 la 65 · Toate sexele · Actualizat 27 aug. 2026 · NCT03167437

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Mercy Medical Center, Baltimore
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 5 aug. 2026 · NCT07237516

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • The Johns Hopkins Children's Medical Center, Baltimore
În curs de recrutareFaza 4
Vârste de la 6 la 17 · Toate sexele · Actualizat 27 mai 2026 · NCT05781152

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Woodholme Gastroenterology Associates, Glen Burnie
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 22 mai 2026 · NCT06764615

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Johns Hopkins University, Baltimore
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 5 mai 2026 · NCT04779320

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.